REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell rewiring offers new hope for tough lupus cases
Disease control Recruiting nowThis study tests a one-time treatment using a patient's own immune cells, modified to target and destroy specific cells causing lupus. It is for adults with severe lupus that has not improved with standard therapies. The goal is to see if this approach can safely control the dise…
Matched conditions: REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 17, 2026 04:49 UTC
-
New cell therapy trial offers hope for tough lupus cases
Disease control Recruiting nowThis study is testing an experimental injection called GC012F in people with systemic lupus erythematosus (SLE) that hasn't responded well to standard treatments. Researchers will enroll 118 participants to check if the treatment is safe and if it helps reduce lupus symptoms over…
Matched conditions: REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE1, PHASE2 • Sponsor: Gracell Biotechnologies (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Apr 22, 2026 15:59 UTC